Search This Blog

Tuesday, April 2, 2019

Amazon’s use of HSAs opening doors for new solutions to out-of-pocket expenses

Amazon’s recent announcement that it will be accepting health savings account (HSA) cards for medical supplies sold on its e-commerce site marked a big step for the company’s evolving role in the healthcare space and may also push more consumers to take an interest in HSAs.
In addition, retail-meets-healthcare platforms such as this one represent the growing collaboration of private insurance plans and consumers in paying for out-of-pocket expenses, experts say.
Lisa Zamosky, senior director of communications at eHealth.com, said during the Affordable Care Act’s last open enrollment period, 23% of people who do not receive government ACA subsidies selected HSA-eligible plans at eHealth—that figure has been pretty stable at eHealth for several years. But on a broader scale, that number is even more dramatic, with enrollment growing fourfold between 2007 and 2017, Zamosky told FierceHealthcare.
“More than half of all employees in the U.S. have a high deductible health plan, meaning they are eligible for an HSA. The problem is that HSAs are still widely misunderstood and underutilized by consumers,” David Vivero, founder and CEO of digital health company Amino, told FierceHealthcare. “By accepting HSA dollars, Amazon is not only giving consumers across the country more options to save on medical expenses, but also hopefully exposing more consumers to the unparalleled benefits of this great healthcare savings tool.”
As consumers’ cost-sharing in healthcare has gone up, financial concerns for medical expenses now outrank concerns for mortgages, taxes and unemployment.
Steve Auerbach, CEO of Alegeus, says Amazon’s move into healthcare may prove to be a great example of industry consolidation with the goal of making shopping for healthcare as easy as other retail purchases.
And, if any brand can bring awareness and popularity to HSAs, it’s Amazon. The e-commerce giant already has a loyal consumer base and a convenient online platform, the experts said. Plus, with an increased emphasis on consumer data as a tool for personalization, Amazon will have a front seat to collecting valuable information.
One of the main challenges with HSAs, which Vivero says Amazon can help with, is the confusion for consumers around which purchases are HSA eligible. Amazon already lends itself to an easy space for defining which products are eligible for HSA purchase right there on the screen.
But HSAs can be used for a long list of qualifying medical expenses, including copays and deductibles, some first aid supplies and over the counter medicines, prescription glasses and contacts, dental services, maternity supplies and fertility treatments, and lots more.
There are other challenges to understanding the platform, too. For example, seven in 10 consumers mistakenly think their HSA is governed by a “use it or lose it” policy like an FSA.
And while some people are weary of calling participants healthcare “consumers,” Vivero believes there is no other way to look at it. Kaiser Family Foundation data show deductibles have risen eight times faster than wages, forcing people to make tough choices about healthcare.
“If you have a high deductible health plan, your HSA is your best tool for saving money on healthcare expenses because it is triple tax-advantaged,” Vivero said. “You can contribute pre-tax dollars, grow those dollars via tax-free investment, and pay for eligible items tax-free as well. The HSA is actually the most tax-advantaged savings account in the country.”

Vivero does warn that consumers generally don’t contribute enough to their HSA and that if they have the means, they should “max out” their HSA—or even better, invest it and grow the HSA dollars tax-free.
“Unfortunately, some people who buy HSA-eligible plans for themselves and their families underfund their health savings account. Some, in fact, never get around to opening an account, and so totally miss out on the benefits of an HSA,” Zamosky said.
According to the Aite Group, out-of-pocket healthcare spending in 2018 was predicted to be $371 billion. Yet, that same report indicates that only $86.3 billion of that spending would flow through tax-advantaged benefit accounts. Auerbach notes that assuming an average tax rate of 30%, consumers left nearly $85 billion in tax savings unclaimed last year.
So, what does the future hold for HSAs and healthcare consumerism?
Auerbach believes that Amazon’s emergence is just the latest example of how consumer-driven healthcare continues to grow in popularity. And as the healthcare market continues its focus on driving affordability and financial responsibility, other big retailers will make similar moves.
Plus, he says, industry consolidation and simplification will continue to merge business models between care delivery, insurance and funding.
“While many of the current acquisitions and partnerships will provide access to two-out-of-three of these pillars, the real winners will be those that can integrate all three, resulting in unchartered integration and simplification within the healthcare industry,” Auerbach said.
And while no one can predict the political future, Zamosky says that an all-public healthcare system seems unlikely.

“The U.S. has a long history of successful public private partnerships in healthcare, as in other fields, and it seems this is likely the way forward as well,” she said. “Experience shows us that public/private collaboration like what we see with the very successful and growing Medicare Advantage program is often appealing and of great benefit to American healthcare consumers.”
And Zamosky suspects HSAs will remain an important part of healthcare benefits. There have been proposals in recent years to broaden their use by eliminating certain restrictions on the accounts and raising the maximum tax-free contribution—but that will take bipartisan legislation.
Auerbach agrees that consumer-driven healthcare will continue to be a powerful tool to help address the crisis in the U.S. healthcare system. According to Mercer, 72% of large employers will offer a consumer-driven health plan in 2019, compared with 20% a decade ago.
“The success of CDH in reversing the cost trend—together with the recent rise in HSA adoption—confirms that CDH will continue to thrive into the future,” Auerbach said.
However, he warns that for the consumer-driven market to continue its growth in the coming years, there needs to be major improvements in the consumer experience. He notes account solutions need to be even more personalized with the help of technologies such as artificial intelligence and machine learning.
“CDH providers are now ready to arm employers and consumers with the smart tools they need to maximize value and utility. As consumers continue to take increased financial responsibility for their healthcare journeys, demand for an improved user experience will only grow,” he added.

ADMA Biologics receives Department of Health and Human Services U.S. license

ADMA Biologics, Inc. announced that the U.S. Food and Drug Administration has issued a Department of Health and Human Services U.S. license No. 2019 to the company in connection with the approval of ASCENIV Immune Globulin Intravenous, Human – slra 10% Liquid. The license covers the Boca Raton, FL manufacturing facility which has demonstrated compliance with FDA requirements as well as authorizes ADMA to manufacture and enter into interstate commerce with ASCENIV.

Dr Reddy to sell, assign US dermatology brands rights to Encore Dermatology

Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO®(betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISEB®Topical Cream and TRIANEX®0.05% (Triamcinolone Acetonide Ointment, USP) in the United States, to Encore Dermatology.
Under the terms of the agreement, Promius Pharma is eligible to receive an upfront payment and future milestone payments contingent upon achievement of certain commercial objectives.
“This is in line with our renewed strategy to enable us achieve self-sustainability and profitable growth for each of our businesses,” said G.V. Prasad, Co-Chairman and CEO, Dr. Reddy’s.

Natus Medical announces accretive sale of Medix business

Natus Medical announced that it has signed a definitive agreement to sell its wholly-owned subsidiary, Medix Medical Devices, SRL, in an employee led buyout. As part of this divestiture, Natus will sell the Medix line of products, including incubators, warmers and other Medix products. Under its new ownership, Medix will continue to distribute Medix products as well as the previously distributed line of Natus products and other third party products in Argentina and Venezuela. Medix will also provide ongoing customer service, sales and customer support, and warranty and repair services for the Medix line of products.”This divestiture is an important step toward refocusing our business on our core products and investing in the markets we expect to grow in the future,” said Jonathan A. Kennedy, President and CEO of Natus. “We remain committed to the markets we serve, and will ensure a smooth and orderly transition for our customers and employees.” The Medix business generated $7.6M of revenue in 2018 and was expected to contribute approximately $6M to 2019 revenue. The divestiture of Medix is expected to be accretive to Natus’ operating income margin going forward. We anticipate incurring $3M to $4M of transaction and disposal expenses as part of the divestiture. We will update full year revenue guidance with the impact of this divestiture in our Q1 2019 earnings release.

Deferred umbilical cord clamping could save many premature infants

New research shows delayed umbilical cord clamping improves survival and reduces risk of brain injury in extremely premature infants.
A baby’s is typically clamped and cut immediately after birth. Over the years, emerging research has suggested there may be benefits to delaying umbilical cord clamping in term neonates. However it was not clear if this intervention would also have benefits on the survival of extremely low gestational age preterm neonates.
In a new study published in JAMA Network Open, neonatologist Dr. Abhay Lodha, MD, and his research team found for the first time that delaying umbilical cord clamping in extremely preterm babies improves their survival. It also lowers the odds of severe neurological injury in the form of an intraventricular hemorrhage, or bleeding in the brain.
“Delaying cord clamping allows time for the baby’s  to stabilize,” says Lodha, associate professor in the departments of Paediatrics and Community Health Sciences at the Cumming School of Medicine and a member of the Alberta Children’s Hospital Research Institute. “As premature babies’ brain vessels are quite fragile, a rapid change in blood pressure can rupture their blood vessels, causing a brain hemorrhage.”
In this , researchers analyzed the outcomes of 4,680 neonates across Canada who were born at 22 to 28 weeks and were admitted to a neonatal intensive care units (NICU). The study suggests deferred umbilical cord clamping (DCC) leads to circulatory stability, which improves blood pressure and reduces the need for transfusions.
The researchers also found DCC reduced the risk of infection by allowing the newborn to receive more nutrient- and immune cell-rich  from the mother.
“As long as the baby is stable at the time of birth, we recommend delaying umbilical cord clamping for 30 to 60 seconds,” says Lodha. “This is a simple intervention that could reduce the need for medication to treat hypotension, reduce the risk of infections, and improves the baby’s survival. We hope this new information will have a global impact, especially in developing countries, and save many premature neonates.”
Going forward, the research team plans to study the long term neurodevelopmental outcomes of preterm neonates who received DCC at birth.

Explore further

More information: Abhay Lodha et al. Association of Deferred vs Immediate Cord Clamping With Severe Neurological Injury and Survival in Extremely Low-Gestational-Age Neonates, JAMA Network Open (2019). DOI: 10.1001/jamanetworkopen.2019.1286

New thermal ablation method for adenoma shows promise

Researchers from the USA (Kansas State University) and the Republic of Ireland (the National University of Ireland Galway) have completed a successful initial test of a new microwave thermal ablation technique, which could eventually be used to treat Conn’s syndrome.
Conn’s syndrome occurs when a benign adrenal gland adenoma causes the production of excess aldosterone, which leads to high blood pressure. Treatment for the condition is currently limited to two options: an adrenalectomy or intensive medical management with significant side effects.
The researchers’ new technique, explained in Biomedical Physics and Engineering Express, could ultimately lead to a non-invasive treatment of small adenomas of up to 20 mm in size, without damaging surrounding tissue.
Hojjatollah Fallahi from Kansas State University, USA, is the study’s lead author. He said: “Microwave Ablation (MWA) is a form of thermal  most often used to treat cancer. It uses  in the microwave energy spectrum (300 MHz to 300 GHz) to heat tissue.
“However, tumour ablation devices and systems were developed to treat large tumours, by maximizing the size of the ablation zone. We wanted to overcome the challenge for adrenal ablation, where the objective is to treat small adenomas while minimizing thermal damage to non-targeted adrenal tissue and preserving adrenal function.”
The international team suspected that water-cooled monopole antennae, operating at 2.45GHz and 5.8GHz, would allow the creation of short, round ablation zones from 10 to 20 mm in diameter.
To test this theory, they used a combination of computer modelling and ex vivo experiments with cow liver and adrenal gland tissue to investigate the ability to control ablation zone size, by adjusting antenna operating frequency, applied power, ablation duration, and coolant temperature.
Mr Fallahi said: “We found that small spherical ablation zones with diameters in the range of 7.4 – 17.6 mm can be obtained by adjusting the applied power and ablation duration. An analysis of the experimentally-measured ablation zone dimensions showed that frequency of operation and ablation duration are the main parameters for controlling the ablation zone length and width, respectively.
“We also discovered that the coolant temperature provides another effective parameter for controlling the ablation zone length, without affecting the ablation zone width.
“Our results demonstrate the feasibility of creating small spherical  zones, suitable for targeting benign adrenal adenomas. Further work is now needed to examine the applications of the technique in more depth and establish if it is suitable for use in human patients with Conn’s syndrome.”

Explore further

More information: Hojjatollah Fallahi et al. Microwave antennas for thermal ablation of benign adrenal adenomas, Biomedical Physics & Engineering Express (2019). DOI: 10.1088/2057-1976/ab068b

Come for fillings, stay for fillers: Some dentists offer Botox, cosmetic treatments

After a plastic surgeon’s office botched her dermal fillers, Tima Barkeshli found a different destination for cosmetic treatments: her dentist’s office.
From his suite in Columbia, Md., Dr. Javod Gol is among the ranks of dentists who are increasingly treating not only the teeth, but everything that frames them. In addition to teeth-cleanings, crowns and cavity fillings, he offers patients like Barkeshli Botox, dermal fillers and small sutures that lift and tighten their skin.
“It rejuvenates your face, which is what I’m looking for,” Barkeshli, a 33-year-old Bethesda, Md., resident, said of the Botox and fillers she’s received from Gol. “I’m not looking to look different. I’m not even looking to look so much younger. It’s more like I want to look fresh and rejuvenated.”
For more than a decade, regulatory boards have authorized the use of botulinum toxin—known under the popular brand name Botox—and other non-surgical cosmetic procedures by dentists. In addition to its cosmetic applications, Botox can be used to treat temporomandibular joint disorders—which cause pain where the jaw and cheek bones meet—as well as conditions like migraines and teeth grinding.
“This was pretty much a natural extension as more and more regulatory dental boards accepted the use of Botox and fillers as the standard of practice in dentistry,” said Dr. Louis Malcmacher, president of the American Academy of Facial Esthetics, which trains dentists and other health care professionals in applying the treatments. “More and more dentists are adopting the use of them every single day.”
With three levels of certification from the American Academy of Facial Esthetics, Gol’s cosmetic work ranges from procedures as simple as injecting Botox to smooth fine lines on the forehead, to the more complex “Nefertiti lift,” which tightens skin along the neck and jawline.
Dentists’ familiarity with facial anatomy makes them reliable providers for facial injections, Malcmacher said, adding they also understand how to treat complications that could arise.
“The face is where dentists live most of their professional life,” Malcmacher said. “Dentists for years have been certainly taking care of teeth but certainly have been involved in all the soft tissues around the mouth.”
Though the smile is the focus of dentists’ work, Gol said he likes to think beyond patients’ teeth.
“If you spend 10(,000) or 20,000 dollars on your teeth, it’s like a perfect piece of artwork, OK,” Gol said. “You’re not going to go and get a piece of artwork and put it in a $10 frame; you want it framed properly.”
Facial cosmetic work is not a fit for every practice, said Dr. Charles Doring, an instructor at the University of Maryland School of Dentistry. His family practice, North Bethesda Dental Associates, for example, treats patients ranging from young children to centenarians. Cosmetic facial treatments are not something his clients are asking for.
“For me it’s just not something I want to offer,” Doring said. “There’s a place for it, but it doesn’t fit into my practice M.O.”
Malcmacher estimated 18 to 20 percent of dentists have been trained in these procedures.
But about 10 percent of Gol’s dental patients seek Botox, fillers and other non-dental cosmetic treatments, he said. The most common Botox injection sites for his patients are the forehead, “crows feet” on the outsides of the eyes, and the “elevens,” or the glabellar complex between the eyebrows. With fillers, he often injects the lips (thanks, Kardashians), nasolabial folds (also known as laugh lines) and cheeks.
Botox treatments range from about $200-$600, while fillers cost about $500-$700 per syringe. Insurance does not typically cover cosmetic procedures.
Gol said he typically treats dynamic wrinkles with Botox first, to relax the muscles that cause lines on the skin. He then follows by treating static wrinkles with fillers, which help plump areas where people lose fat as they age.
“I would rather give you something that fits your face as opposed to giving something that everybody else gets,” Gol said. “What our body should take is different, so it really needs to be customized to you.”
He also tries to accentuate patient’s natural features, he said.
“Somebody who is like 45—they shouldn’t be getting fillers to look like they’re 25. When you’re 45 you can still look beautiful at 45, so let’s make you look like a beautiful 45-year-old,” Gol said. “What you want maybe isn’t the best for you.”
Such conversations with patients help determine their best course of treatment.
“That kind of patient-doctor relationship is very special in dentistry,” Malcmacher said. “And where that really comes in on the clinical side is I know my patient’s face, I’ve dealt with them for years.”
Baltimore resident Shane Gabriszeski said he’d been seeing Gol for about three years for his dental needs. He more recently began seeing him for Botox.
“One day in his office he asked me if I’d ever considered Botox for a wrinkle in my forehead that’s been there since I was a teenager,” he said. “It’s always bothered me but never enough to do anything about it.”
He tried it for the first time about 18 months ago, and goes back about every four months for injections. And Gol recently placed a PDO thread—a tiny suture that lifts the skin, dissolves and builds collagen—to give his skin a stronger lift.
“A lot of people might be hesitant to go to a dentist, but he is really good,” Gabriszeski, 33, said.
When Barkeshli found out Botox was an option at Gol’s office, she said she was glad to receive the treatments from a doctor she already trusted. She, too, was a dental patient first.
“The person who does it does matter, and I think it’s more experience than anything else,” she said. “He’s super easy on my teeth, so I like that, and then the same with the fillers.”
The results keep patients coming back, Gol said.
“Patients are a lot happier getting this than they are getting their dental work” Gol said. “Positive reinforcement has been the biggest thing for it—the fact that it’s something that makes people feel good and makes you want to do it again.”